| Patient Snapshot: Jeff M., a middle-aged male, presents with goals of mental calmness, balanced energy, and improved focus. He maintained a rigorous CrossFit regimen and a stable weight (~210 lbs) on a meat-forward diet with a limited variety of produce. Current medications included a long-term stimulant (15 years), an atypical antipsychotic (5 years), and an inhaled corticosteroid for asthma. Sleep averaged 5–6 hours per night. History notable for intermittent anxiety, possible cyclothymic traits, and a family history of mood disorders and addiction. Readiness for change: 10 out of 10. |
Introduction
This case illustrates a central principle of functional medicine: when a patient presents with mental health symptoms that haven’t fully responded to conventional treatment, the answer often lies outside the brain. By systematically investigating root-cause drivers across multiple biological systems, we uncovered a coherent pattern in which gastrointestinal dysfunction was cascading into stress hormone dysregulation, neurotransmitter imbalance, immune activation, and early metabolic disruption—all converging on Jeff’s lived experience of anxiety, fatigue, and impaired focus.
Jeff had been on psychiatric medication for over a decade. The medications were helping—but not enough. He still lacked the calmness, energy, and cognitive clarity he was seeking. Rather than adding more medication or increasing doses, our approach was to look beneath the symptoms and ask: What is driving these patterns at a biological level, and what can we do about it?
Comprehensive Functional Medicine Testing
Jeff completed the FxMed Mental Health testing bundle, a panel of six complementary assessments designed to provide a 360-degree view of biological function. Each test provides a distinct lens; together, they reveal patterns that no single test could identify.
The Testing Panel
Comprehensive Serum Panel — Standard blood chemistry including complete metabolic panel, CBC with differential, lipid panel, thyroid panel, iron studies, inflammatory markers (hs-CRP), fasting insulin, hemoglobin A1c, cortisol, DHEA-S, vitamin D, magnesium, zinc, copper, and homocysteine.
DUTCH Plus (Precision Analytical) — Dried urine test for comprehensive hormones, providing a full cortisol rhythm map (including the cortisol awakening response), sex hormone metabolites, and organic acid markers related to neurotransmitter metabolism, including dopamine, norepinephrine, and melatonin.
GI Effects Comprehensive Profile (Genova Diagnostics) — Advanced stool analysis assessing microbiome composition, inflammation markers, digestive function, and screening for pathogens and yeast.
FIT 176 + Gut Barrier Panel (KBMO Diagnostics) — Food sensitivity testing measuring IgG and complement (C3d) reactivity to 176 foods, plus markers of intestinal permeability including zonulin, LPS antibodies, occludin, and Candida antibodies.
NutrEval FMV (Genova Diagnostics) — Functional nutritional assessment evaluating organic acids, fatty acid balance, oxidative stress, mitochondrial function, methylation status, and toxic element exposure.
3×4 Genetics + Blueprint Report — Genetic panel analyzing clinically relevant variants across methylation, detoxification, neurotransmitter metabolism, nutrient handling, cardiometabolic tendencies, and immune susceptibility.
Key Findings: A Coherent Biological Story
What made Jeff’s case compelling was not any single abnormal result. It was the convergence. Six independent tests, each measuring different aspects of physiology through different methodologies, told a remarkably consistent story.
Primary Driver: Severe Gastrointestinal Dysbiosis
Jeff’s stool analysis revealed a dysbiosis score of 10 out of 10—the highest possible. This was not subtle. He had markedly elevated levels of methane-producing archaea (Methanobrevibacter smithii) and the inflammatory organism Collinsella aerofaciens, while Lactobacillus—a genus critical for GABA production, immune modulation, and gut-brain signaling—was completely undetectable. Calprotectin, a marker of intestinal inflammation, was mildly elevated, confirming low-grade colonic inflammation.
The nutritional assessment independently corroborated this picture: tartaric acid was elevated (a marker of yeast/fungal overgrowth) and benzoic acid was mildly high (consistent with bacterial overgrowth). These weren’t just abstract lab numbers—they explained Jeff’s constipation during inactivity (methane slows gut transit) and contributed to the neuroinflammatory signaling that was undermining his mental health goals.
Intestinal Permeability: The Barrier Had Been Breached
The Gut Barrier Panel showed positive zonulin IgA and LPS IgA antibodies, indicating mucosal permeability—commonly known as “leaky gut.” Jeff’s body was mounting an immune response against both the gatekeeper protein (zonulin) that regulates the tight junctions between intestinal cells, and against lipopolysaccharide (LPS), a potently inflammatory molecule derived from gram-negative bacteria.
Importantly, the IgG markers were negative, indicating mucosal-level permeability rather than systemic permeability. We had caught it before it had progressed to a full systemic inflammatory process—but it was actively driving immune activation and food sensitivities.
Food Immune Reactivity: Genetics and Immune Function Converge
The food sensitivity panel revealed severe reactivity to wheat gluten and Brazil nut, with high reactivity to wheat gliadin, whole wheat, carrot, and sweet potato. The genetic panel confirmed HLA DQ2.2—a variant that substantially increases susceptibility to gluten-related immune activation.
This triad—genetic susceptibility (HLA DQ2.2), active immune reactivity, and confirmed intestinal permeability—made gluten elimination not just a temporary intervention but a foundational, likely permanent therapeutic strategy. It also contextualized the other food sensitivities as downstream consequences of impaired barrier function rather than true fixed allergies.
Stress Hormone Dysregulation: A Rhythm Problem, Not a Production Problem
The DUTCH Plus revealed a classic pattern: a blunted cortisol awakening response (CAR) combined with elevated evening cortisol. In healthy physiology, cortisol spikes 50–70% upon waking—our “get up and go.” Jeff’s morning cortisol values were low to low-normal across the waking, +30, and +60 minute measurements. Paradoxically, cortisol was elevated at dinner and bedtime, exactly when it should be at its lowest.
This pattern—sometimes called Stage 2 HPA axis dysfunction or early decompensation—explained Jeff’s difficulty getting going in the morning, reliance on stimulant medication for activation, and inability to achieve restful sleep. Total cortisol production was normal, and DHEA levels were reassuringly intact on both serum and urinary measures. This was a rhythm problem, not an exhaustion problem—a crucial distinction that shaped our treatment strategy.
The serum cortisol, drawn in the morning, was elevated above lab reference ranges. Rather than contradicting the DUTCH findings, this confirmed the dysregulated pattern—a snapshot measurement capturing a different phase of the same disrupted rhythm.
Neurotransmitter Metabolism: Low Dopamine Turnover Meets Genetic Context
Both the DUTCH Plus and NutrEval independently showed low homovanillic acid (HVA)—the primary metabolite of dopamine. Vanillylmandelic acid (VMA), reflecting norepinephrine/epinephrine metabolism, was low-normal. And 6-hydroxy-melatonin sulfate, the main urinary metabolite of melatonin, was low-normal, indicating relative melatonin insufficiency.
The genetic panel provided the critical context: Jeff carried the COMT Val/Val genotype. COMT (catechol-O-methyltransferase) is the primary enzyme that breaks down dopamine and other catecholamines. Val/Val means faster-than-average catecholamine clearance—which explains both why stimulant medication has been effective for Jeff (it compensates for rapid dopamine clearance) and why low HVA is consistent with his biology rather than pathological.
The nutritional assessment also showed mildly elevated 5-HIAA (a serotonin metabolite), suggesting increased serotonin turnover. Notably, the kynurenic-to-quinolinic acid ratio was favorably high, representing a protective trend in tryptophan metabolism. These neurotransmitter patterns, combined with the gut-brain axis dysfunction from severe dysbiosis, created a neurochemical environment that was undermining calmness, focus, and emotional regulation.
Metabolic Early Warning Signs
Fasting glucose was mildly elevated at 102 mg/dL (normal is under 100), placing Jeff in the impaired fasting glucose range. Hemoglobin A1c remained normal, so prediabetes had not yet developed. However, the genetic panel showed variants in multiple metabolic genes (FTO, MC4R, LEPR, ADIPOQ, TCF7L2) associated with higher weight set-point and impaired glucose regulation. The lipid panel was pristine—all values in desirable ranges—suggesting we had time to intervene before metabolic dysfunction progressed.
The Iron Paradox
Jeff’s genetic panel showed HFE variants associated with increased iron absorption. Yet serum iron was actually low (52 µg/dL; reference 65–175) and hematocrit was slightly below range. Ferritin was normal, so frank anemia had not developed. This paradox—genetics predicting high absorption but real-world levels showing deficiency—pointed directly to the gut dysfunction. Intestinal inflammation and dysbiosis were likely impairing iron handling, overriding the genetic tendency. It was a powerful example of why we treat the patient in front of us rather than treating genetics in isolation.
What Was Working Well
| Strengths Identified Across Testing Mitochondrial function: excellent (normal CoQ10, strong glutathione, normal lipid peroxides). Methylation: intact despite MTHFR C677T heterozygous status. Omega-3 status: robust (elevated EPA, DHA, DPA—fish oil supplementation was clearly effective). Estrogen metabolism: favorable 2-OH:16-OH ratio indicating healthy estrogen detoxification. Oxidative stress management: strong endogenous glutathione production. |
Connecting the Dots: A Systems Biology Interpretation
Functional medicine emphasizes that chronic illness is rarely about one broken thing—it’s about interconnected systems falling out of balance. Jeff’s case was a textbook example. The central driver was gut dysfunction: severe dysbiosis, mucosal permeability, mild colonic inflammation, yeast signals, and absent Lactobacillus. This was cascading into multiple downstream effects.
Gut → Brain: The dysbiotic microbiome was disrupting neurotransmitter precursor production (absent Lactobacillus means reduced GABA synthesis), generating inflammatory signaling through LPS translocation, and contributing to the neuroinflammatory load undermining mental calmness and focus.
Gut → Stress Hormones: Chronic low-grade immune activation from intestinal permeability is a known driver of cortisol rhythm dysregulation. The blunted morning cortisol and elevated evening cortisol were downstream consequences of a system under chronic inflammatory stress.
Gut → Metabolism: Dysbiosis influences glucose metabolism through altered short-chain fatty acid production and inflammatory signaling. The early metabolic warning signs (impaired fasting glucose) likely reflected gut-driven disruption layered on top of genetic susceptibility.
Gut → Nutrient Status: The iron paradox—genetically favored absorption yet functionally low levels—pointed to inflammation-mediated malabsorption at the gut level.
This interconnected pattern suggested that systematically addressing gut dysfunction could improve downstream outcomes: cortisol rhythm, neurotransmitter balance, immune activation, metabolic markers, and nutrient absorption. Jeff’s treatment plan was designed accordingly.
Treatment Protocol: A Three-Phase Approach
Treatment was structured across three phases spanning approximately four months, following a systems biology framework. The overarching strategy was to prioritize gut restoration first (using the functional medicine 5R model: Remove, Replace, Repopulate, Repair, Rebalance), then address stress hormone and neurotransmitter optimization, and finally consolidate gains into a sustainable maintenance plan.
Supplement timing was organized around four daily windows—upon awakening, with breakfast, with dinner, and before bed—to maximize absorption, minimize interactions, and keep the regimen realistic. All interventions were carefully screened for interactions with Jeff’s current medications.
Medication Considerations
Jeff’s existing medication regimen required careful attention. The long-term stimulant depletes magnesium, B-vitamins, and vitamin C while suppressing appetite. The atypical antipsychotic must be taken with adequate calories for absorption and carries metabolic effects relevant to impaired fasting glucose. Its CYP3A4 metabolism contraindicated grapefruit seed extract, and its serotonergic properties meant we avoided isolated 5-HTP supplementation in favor of dietary tryptophan strategies. The inhaled corticosteroid was noted as a potential contributor to stress hormone patterns over time.
The protocol was designed to work alongside these medications—optimizing the biological substrate rather than replacing pharmaceutical support. Any future medication adjustments would be gradual and coordinated with the prescribing clinician.
Phase 1: Gut Restoration and Foundation (6 Weeks)
Phase 1 targeted the primary driver: severe dysbiosis, mucosal permeability, and inflammation. This phase also established circadian and sleep foundations critical for stress hormone recovery.
Nutrition Interventions
Given the convergence of HLA DQ2.2 genetics, severe wheat/gluten immune reactivity, and confirmed intestinal permeability, gluten elimination was established as a foundational and likely permanent intervention. Additional eliminations based on food sensitivity results:
- Strict elimination (6+ weeks): All wheat and gluten, Brazil nuts, carrots, sweet potatoes
- Moderate elimination (4 weeks, then challenge): Almond, turkey
- Fiber diversity protocol: Graduated increase to 35–40g fiber daily, emphasizing prebiotic-rich foods (leeks, onions, garlic, asparagus, slightly green bananas) and resistant starch (cooled rice, cooked and cooled potatoes)
- Motility support: Fresh ginger tea 2–3x daily, ground flaxseed (2 tbsp daily), warm lemon water upon waking
- Fermented foods: Sauerkraut and kimchi introduced gradually (1–2 tbsp daily, increasing over time) to support microbiome recolonization
- Dietary diversity target: 30+ different plant foods weekly to support microbiome recovery while maintaining adequate protein for CrossFit demands
Lifestyle Interventions
Because Jeff’s cortisol disruption was a rhythm problem, light-based circadian interventions were prioritized as the most powerful free tools available:
- Morning light exposure: 10–15 minutes of outdoor light within 30 minutes of waking (non-negotiable)
- Evening light restriction: Blue-blocking glasses after sunset, screens off 60–90 minutes before bed
- Sleep targets: Consistent bed time of 10pm, consistent wake time, cool temperature (65–68°F), complete darkness; goal of 7–8 hours (up from baseline of 5–6)
- Evening wind-down: Post-dinner walk (15–20 min), Epsom salt baths 2–3x weekly, 4-7-8 breathing (inhale 4, hold 7, exhale 8) x 4 cycles before bed
- Exercise modification: Maintain CrossFit 4–5x/week but add 1–2 dedicated recovery days; no high-intensity training within 4 hours of bedtime
Phase 1 Supplement Protocol
Jeff’s Phase 1 supplement schedule, organized across four daily time windows:
| ☀ Upon Awakening (~6:30 AM) | |
| Warm lemon water | Stimulates gastric motility and bile flow |
| L-Glutamine 5g | Mucosal repair; taken 20 minutes before food |
| Morning light exposure | 10–15 min outside (circadian reset, non-supplement) |
| 🍳 With Breakfast (~7:00 AM) | |
| Vitamin D3 5,000 IU | Immune modulation; genetic VDR variants support higher dosing |
| S. boulardii 5 billion CFU | Probiotic yeast; protective during antimicrobial phase |
| Fish Oil 2,000mg | Continue existing (omega-3 status confirmed robust on testing) |
| CoQ10 300mg | Continue existing (mitochondrial status confirmed intact) |
| Stimulant medication | As prescribed |
| Antipsychotic medication | As prescribed (requires ≥350 calories for absorption) |
| 🍗 With Dinner (~6:30 PM) | |
| Zinc 30mg | Immune function, intestinal barrier integrity |
| Oregano Oil 150mg | Botanical antimicrobial (starting Week 3) |
| Berberine 500mg | Antimicrobial + metabolic support via AMPK activation (starting Week 3) |
| Creatine | Continue existing (supports dopamine system, especially with COMT Val/Val) |
| Ginger tea | Motility and anti-inflammatory support |
| 🌙 Before Bed (~9:30 PM) | |
| Magnesium Glycinate 300–400mg | Sleep, stress response, repletes stimulant-driven depletion |
| Blue-blocking glasses | Worn after dinner (circadian support, non-supplement) |
| 4-7-8 breathing x 4 cycles | Parasympathetic activation (non-supplement) |
Antimicrobial Strategy (Weeks 3–6)
Given Jeff’s 10/10 dysbiosis score with elevated methanogens and yeast markers, a botanical antimicrobial protocol was introduced in Week 3—after the fiber and motility foundation was established. Oregano oil and berberine were dosed twice daily (with lunch and dinner). Berberine offered dual benefit for Jeff’s impaired fasting glucose through AMPK activation. A pharmaceutical option (rifaximin plus neomycin, the standard methane-dominant protocol) was available as escalation if botanicals proved insufficient, but the gentler approach was chosen first given the moderate inflammatory presentation.
Phase 2: Stress Hormone Optimization and Neurotransmitter Support (4 Weeks)
Phase 2 built on gut restoration gains by targeting cortisol rhythm and dopamine system function directly.
Nutrition Adjustments
- Tryptophan-rich evening meals: Salmon, eggs, pumpkin seeds, combined with carbohydrate (rice, quinoa) to enhance brain uptake—a safe serotonin precursor strategy compatible with Jeff’s medication
- Tyrosine-rich morning meals: Eggs, beef, chicken, fish—supporting dopamine precursors through food rather than isolated supplements, avoiding stimulant potentiation
- Dark chocolate protocol: 20–40g of 85%+ dark chocolate mid-afternoon; evidence supports flavonoid-mediated cortisol modulation
Lifestyle Additions
- Vagus nerve activation: Graduated cold exposure (30–60 seconds at end of shower), vigorous gargling 1–2x daily, humming/singing
- Box breathing: Inhale 4, hold 4, exhale 4, hold 4—five minutes, twice daily for direct stress hormone modulation
- Foam rolling: Full-body routine (~40 minutes, minimum weekly) for recovery and nervous system regulation
Phase 2 Supplement Adjustments
Phase 2 discontinued the oregano oil (completed 4-week course) and introduced targeted stress hormone and neurotransmitter support:
| 🍗 Added With Dinner | |
| Phosphatidylserine 100–200mg | Lowers elevated evening cortisol; supports cognitive function |
| Ashwagandha (KSM-66) 300mg | Adaptogen; evening dosing chosen to target Jeff’s elevated PM cortisol specifically |
| 🌙 Added Before Bed | |
| Melatonin 0.5mg | Physiologic dose to prime circadian signal; Jeff’s testing showed melatonin insufficiency |
Why low-dose melatonin? Evidence increasingly supports physiologic doses (0.3–1mg) over the 3–10mg doses commonly sold over the counter. Jeff’s testing documented genuine melatonin insufficiency, making low-dose supplementation a targeted intervention to restore circadian signaling. Higher doses often suppress endogenous production and cause next-day grogginess—the opposite of what we were trying to achieve.
Why evening ashwagandha? Ashwagandha is appropriate across a range of stress hormone patterns. For Jeff’s specific presentation—where elevated evening cortisol was more prominent than depleted morning cortisol—evening dosing made the most clinical sense. A patient with profound morning fatigue and no evening elevation might instead warrant a morning adaptogen like rhodiola.
Phase 3: Resilience and Maintenance (Ongoing)
Phase 3 focuses on consolidating gains, reducing supplement burden to a sustainable long-term stack, and systematically reintroducing moderate-reactivity foods.
Food Reintroduction Protocol
After completing the elimination period, foods were reintroduced one at a time using a structured three-day challenge method: eat a normal portion on Day 1, Day 2, and Day 3, then monitor symptoms for 72 hours. The reintroduction order was prioritized by reactivity level:
- First to reintroduce: Almond, turkey (moderate reactivity)
- Later challenges (cautiously): Sweet potato, carrot (high reactivity)
- Permanent elimination: Wheat/gluten (genetic susceptibility + severe reactivity = likely lifelong avoidance), Brazil nuts (severe reactivity)
Long-Term Maintenance Stack
The goal of Phase 3 is to identify the minimum effective supplement regimen for sustained benefit:
| Projected Maintenance Protocol | |
| Fish Oil 2,000mg | With breakfast — continued for omega-3 maintenance |
| Vitamin D3 5,000 IU | With breakfast — continued given genetic VDR variants |
| Magnesium Glycinate 300mg | Before bed — continued for sleep, stress, and medication depletion |
| CoQ10 300mg | With breakfast — continued for mitochondrial support |
| Probiotic (Lactobacillus-containing) | With breakfast — long-term microbiome support given absent Lactobacillus baseline |
| Creatine | With dinner — continued for dopamine system and athletic performance |
Supplements considered for discontinuation if treatment targets are met include melatonin (if sleep architecture normalizes), phosphatidylserine (if evening cortisol normalizes), and ashwagandha (which can be cycled or discontinued based on stress response stability). Follow-up testing—including a repeat stool analysis and cortisol rhythm assessment—is planned to objectively guide these decisions.
Clinical Response
By the early weeks of Phase 2, Jeff reported multiple improvements that aligned directly with our treatment targets:
| Reported Outcomes Improved bowel regularity (directly reflecting reduced methane-dominant dysbiosis and improved motility). Reduced abdominal bloating and inflammation (consistent with gut restoration and food elimination). Strong protocol adherence with high insight and appropriate self-monitoring. Transition from feeling overwhelmed by the protocol’s scope to expressing readiness for fine-tuning rather than major changes. |
These early results are consistent with predictions from the functional medicine literature: when the gut is the primary driver, addressing it systematically tends to produce relatively rapid improvement in GI symptoms, with downstream improvements in energy, mood, and cognition following as the gut-brain axis normalizes. Jeff’s residual muscle tension and sleep variability at this stage were assessed as reflecting training demands and nervous system recalibration rather than acute pathology.
Treatment remains ongoing, with continued emphasis on optimizing stress hormones, sleep architecture, and the gradual dietary reintroduction protocol. Follow-up testing is planned to objectively reassess gut barrier function, dysbiosis markers, and cortisol rhythm.
Clinical Considerations and Controversies
Botanical vs. Pharmaceutical Antimicrobials
There is ongoing debate about the relative efficacy of botanical versus pharmaceutical approaches for dysbiosis. Recent evidence suggests comparable outcomes when botanicals are combined with Saccharomyces boulardii and lifestyle modification. In Jeff’s case, the moderate inflammatory presentation (calprotectin only mildly elevated, no pathogenic bacteria) and strong patient motivation supported the gentler botanical-first approach, with pharmaceutical escalation reserved as a clear next step if needed.
Long-Term Gluten Elimination
The combination of HLA DQ2.2 genetic susceptibility, severe IgG reactivity across multiple wheat fractions, and confirmed intestinal permeability constitutes a case in which gluten elimination is appropriately framed as a permanent lifestyle modification rather than a temporary elimination. This is an important clinical distinction—not all food sensitivities warrant permanent removal, but this triad of genetic, immunologic, and barrier evidence provides strong evidence.
Adaptogens for Cortisol Dysregulation
Ashwagandha is supported for a range of stress hormone patterns, but dosing timing should align with the patient’s specific circadian rhythm. For Jeff—whose elevated evening cortisol was the dominant finding—phosphatidylserine plus ashwagandha was the most targeted approach. A different patient presenting with profound morning fatigue without evening elevation might warrant a different strategy, such as morning rhodiola. This individualization is part of what makes functional medicine effective.
The Iron Paradox: Treating the Patient, Not the Genotype
Jeff’s genetic profile predicted high iron absorption, but his actual iron stores were low. Rather than supplementing iron directly, the decision was to address the gut inflammation that was likely impairing absorption. If iron does not self-correct as the gut heals, lactoferrin (which supports iron absorption and has antimicrobial properties) or iron bisglycinate may be considered. This approach prioritizes treating the underlying mechanism over treating the lab value.
Conclusion
Jeff’s case demonstrates the power of comprehensive functional medicine testing to reveal the biological architecture underlying treatment-resistant mental health symptoms. What appeared clinically as “anxiety, fatigue, and focus problems insufficiently managed by medication” turned out to be a coherent systems biology pattern with a primary gut driver cascading across stress hormones, neurotransmitter metabolism, immune function, and metabolic regulation.
By addressing the root cause—rather than adding more symptomatic treatments—Jeff experienced measurable improvement within weeks. Treatment continues, with the expectation that ongoing gut restoration, circadian optimization, and metabolic support will produce further gains in the areas that matter most to him: mental calmness, balanced energy, and the ability to focus clearly throughout his day.
